Home/Filings/4/0001847903-25-000029
4//SEC Filing

Crowley John J 4

Accession 0001847903-25-000029

CIK 0001847903other

Filed

Feb 3, 7:00 PM ET

Accepted

Feb 4, 4:57 PM ET

Size

5.7 KB

Accession

0001847903-25-000029

Insider Transaction Report

Form 4
Period: 2025-02-03
Crowley John J
Chief Financial Officer
Transactions
  • Award

    Share Option (right to buy)

    2025-02-03+250,000250,000 total
    Exercise: $16.90Exp: 2035-02-03Ordinary Shares (250,000 underlying)
Footnotes (2)
  • [F1]1/48th of the shares subject to such option shall vest and become exercisable in equal monthly installments with the first installment vesting on March 3, 2025.
  • [F2]The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.

Issuer

Centessa Pharmaceuticals plc

CIK 0001847903

Entity typeother

Related Parties

1
  • filerCIK 0001587972

Filing Metadata

Form type
4
Filed
Feb 3, 7:00 PM ET
Accepted
Feb 4, 4:57 PM ET
Size
5.7 KB